These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21133243)

  • 21. The politics and strategy of industry self-regulation: the pharmaceutical industry's principles for ethical direct-to-consumer advertising as a deceptive blocking strategy.
    Arnold DG; Oakley JL
    J Health Polit Policy Law; 2013 Jun; 38(3):505-44. PubMed ID: 23418365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct to consumer advertising in healthcare: history, benefits, and concerns.
    Adeoye S; Bozic KJ
    Clin Orthop Relat Res; 2007 Apr; 457():96-104. PubMed ID: 17310934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Australian consumer responses to DTCA and other pharmaceutical company sponsored advertisements.
    Hall DV; Jones SC
    Aust N Z J Public Health; 2008 Oct; 32(5):471-8. PubMed ID: 18959553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A contribution to the development of advertising in pharmacy II. Historical development of regulation of advertising of medicinal products].
    Vranová V
    Ceska Slov Farm; 2012 Oct; 61(5):240-3. PubMed ID: 23256658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of the treaty basis on health policy legislation in the European Union: a case study on the tobacco advertising directive.
    Boessen S; Maarse H
    BMC Health Serv Res; 2008 Apr; 8():77. PubMed ID: 18397520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tobacco industry strategies for influencing European Community tobacco advertising legislation.
    Neuman M; Bitton A; Glantz S
    Lancet; 2002 Apr; 359(9314):1323-30. PubMed ID: 11965294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. European policymaking on the tobacco advertising ban: the importance of escape routes.
    Adamini S; Versluis E; Maarse H
    Health Econ Policy Law; 2011 Jan; 6(1):65-84. PubMed ID: 20199714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Filling in the Gaps: Priming and the Ethics of Pharmaceutical Advertising.
    Biegler P
    Kennedy Inst Ethics J; 2015 Jun; 25(2):193-230. PubMed ID: 26144539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of direct-to-consumer advertising on prescription drug use by older adults.
    Datti B; Carter MW
    Drugs Aging; 2006; 23(1):71-81. PubMed ID: 16492071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ban the sunset? Nonpropositional content and regulation of pharmaceutical advertising.
    Biegler P; Vargas P
    Am J Bioeth; 2013; 13(5):3-13. PubMed ID: 23557035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The rabbit in the hat: dubious argumentation and the persuasive effects of prescription drug advertising (DTCA).
    Rubinelli S; Nakamoto K; Schulz PJ
    Commun Med; 2008; 5(1):49-58. PubMed ID: 19363879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The opinions and experiences of family physicians regarding direct-to-consumer advertising.
    Lipsky MS; Taylor CA
    J Fam Pract; 1997 Dec; 45(6):495-9. PubMed ID: 9420585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct-to-physician and direct-to-consumer advertising: Time to have stringent regulations.
    Kannan S; Gowri S; Tyagi V; Kohli S; Jain R; Kapil P; Bhardwaj A
    Int J Risk Saf Med; 2015; 27(2):77-83. PubMed ID: 26410010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct-to-consumer advertising (DTCA) for prescription drugs: consumers' attitudes and preferences concerning its regulation in South Korea.
    Suh HS; Lee D; Kim SY; Chee DH; Kang HY
    Health Policy; 2011 Aug; 101(3):260-8. PubMed ID: 21705104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Legislative and non-legislative regulations concerning Rx drug advertisement in the European Union and the United States--comparative analysis.
    Czerw A; Religioni U
    Acta Pol Pharm; 2012; 69(4):779-87. PubMed ID: 22876622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacy students' opinions of direct-to-consumer advertising: a pilot study at one university.
    Harrington AR; Desselle SP; Apgar DA; Hesselbacher E; Pié A; Quesnel A; Warholak TL
    Res Social Adm Pharm; 2013; 9(4):458-66. PubMed ID: 22999802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of direct-to-consumer advertising (DTCA) on patient health-related behaviors and issues.
    Polen HH; Khanfar NM; Clauson KA
    Health Mark Q; 2009; 26(1):42-55. PubMed ID: 19197587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The rise of digital direct-to-consumer advertising?: Comparison of direct-to-consumer advertising expenditure trends from publicly available data sources and global policy implications.
    Mackey TK; Cuomo RE; Liang BA
    BMC Health Serv Res; 2015 Jun; 15():236. PubMed ID: 26084705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Updated Analysis of Direct-to-Consumer Television Advertisements for Prescription Drugs.
    Applequist J; Ball JG
    Ann Fam Med; 2018 May; 16(3):211-216. PubMed ID: 29760024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.